Sakar Healthcare Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.2x)
Concerns
- Trading near 52-week high (₹1,024)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SAKAR · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 53.15% | 53.15% | 53.15% | 53.15% | 53.58% | 53.58% |
| FII | 13.76% | 13.52% | 13.52% | 13.42% | 13.58% | 13.61% |
| DII | 10.62% | 10.62% | 10.62% | 10.62% | 10.88% | 10.97% |
| Public | 22.47% | 22.71% | 22.71% | 22.80% | 21.96% | 21.85% |
Latest News
All newsSakar Healthcare gets EU, UK, Canada approvals for new products
*Sakar Healthcare gets EU, UK, Canada approvals for new products* — The company has secured new regulatory approvals for its medical devices in Europe, the UK, and Canada. These clearances are tied to collaborations with **7 business partners**, boosting its global footprint. The development supports future revenue diversification and international market penetration. 📊 *STOCKS:* SAKARHEALTH | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Approvals
Sakar Healthcare to hold shareholder meeting on September 22, 2026
*Sakar Healthcare to hold shareholder meeting on September 22, 2026.* The event is scheduled for discussions on corporate matters. No financial figures or strategic announcements disclosed yet. Typically routine in nature, such meetings rarely trigger immediate trading moves. 📊 *STOCKS:* $SAKARHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholderMeeting
Sakar Healthcare hosts investor call for updates
*Sakar Healthcare hosts investor call for updates.* The company held an analyst and institutional investor meet to discuss business performance and strategic developments. Specific financial figures or major announcements were not disclosed. The event aimed to enhance investor engagement and transparency. 📊 *STOCKS:* $SAKARCHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorCall
Sakar Healthcare shares up on investor presentation
*Sakar Healthcare shares reacted positively following its investor presentation.* The filing indicates increased investor outreach but reveals no major financial updates or strategic announcements. Trading volume rose moderately with **no significant price swing** observed. The stock remains in accumulation phase with **low institutional visibility**. 📊 *STOCKS:* SAKARHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorPresentation
Sakar Healthcare files regulatory update for June 2026 quarter
*Sakar Healthcare files regulatory update for June 2026 quarter.* This is a routine compliance disclosure under SEBI (Depositories and Participants) Regulations, 2018. No financial or operational updates included. **No material impact** expected for traders. 📊 *STOCKS:* SAKARHEALTH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Regulatory